The DxH 900 hematology analyzer enables your high volume laboratory to achieve superb RBC, PLT, and WBC differentials through near-native state cellular characterization. Beckman Coulter Inc., is a danaher corporation company that develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing.

Its features are:

• Achieve superb RBC, PLT and WBC differentials through near native-state cellular characterization
• Deliver reliable, reportable WBC differential results on the first run, through VCS 360 technology, DataFusion, and the enhanced Coulter Principle. These core technologies provide high-resolution characterization without altering cell morphology, providing excellent hematological test results;
• Support critical clinical decisions through advanced PLT analysis. The enhanced Coulter Principle provides a reportable MPV- even for thrombocytopenic patients- while DataFusion leverages inter-module intelligence to enable improved flagging and identification of interferences.

Facebook Page of the Product

Twitter Page of the Product

linkedin Page of the Product

Website of the Product

GIT repository link of the Product